Kos Pharmaceuticals Inc - Cranbury, New Jersey 08512

Kos Pharmaceuticals Inc is categorized under in Cranbury, NJ .

Business Name: Kos Pharmaceuticals Inc
Contact Person: Adrian Adams
Address: 1 Cedarbrook Drive, Cranbury, New Jersey 08512
Phone Number: (609) 495-0500
Website Address: abbott.com
Annual Revenue (USD): $100.000.000 to $499.999.999
Founding Year: 2006
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: The Frederick Purdue Company - Cranbury, NJ 08512
Evenus Pharmaceutical Labs Inc - Cranbury, NJ 08512
Endo Pharmaceuticals Solutions Inc - Cranbury, NJ 08512
Cmic Cmo Usa Corporation - Cranbury, NJ 08512
Purdue Pharma Lp - Cranbury, NJ 08512
Endo Pharmaceuticals Inc - Cranbury, NJ 08512
Sun Pharmaceutical Industries - Cranbury, NJ 08512
Palatin Technologies Inc - Cranbury, NJ 08512
Moore Family Realty Inc - Cranbury, NJ 08512
Wyeth LLC - Cranbury, NJ 08512
Amicus Therapeutics Inc - Cranbury, NJ 08512
Cocensys Inc - Cranbury, NJ 08512
Pharmacopeia Inc - Cranbury, NJ 08512
Caraco Pharmaceutical Laboratories Ltd - Cranbury, NJ 08512
P F Laboratories Inc - Cranbury, NJ 08512
Evenus Pharmaceutical Laboratories Inc - Cranbury, NJ 08512

The company Kos Pharmaceuticals Inc provides BOTH services in the form of from its headquarters in New Jersey. 1 to 4 employees work for Kos Pharmaceuticals Inc, and the business now earns $100.000.000 to $499.999.999 per annum.

Kos Pharmaceuticals Inc was launched in 2006 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Kos Pharmaceuticals Inc, please call Adrian Adams with the phone number (609) 495-0500 or visit its headquarters at 1 Cedarbrook Drive in Cranbury, New Jersey 08512.

The location of the headquarters can also be found using the coordinates 40.331891,-74.502591. Read more details about this business on the webpage abbott.com or follow the company’s social media accounts, on Twitter and on Facebook.